We quantify muscle performance and predict time-to-recovery

Enabling smarter performance, recovery, and return-to-play decisions through objective muscle insights.

A hand wearing a blue glove holding a BioSensr device.

The Cost of Hamstring Injuries in Professional Sports

24%

~8   

Of all professional football injuries are hamstring-related [1]

Average hamstring injuries sustained per club per season

High-performance staff currently rely entirely on indirect metrics—such as GPS tracking, force plates, dynamometry, and subjective athlete readiness surveys. While valuable, these methods fail to directly quantify muscle-specific recovery progression or true active neuromuscular function.

The BioSensr Platform

  • Hardware Unit: A flexible, skin-stable surface electromyography (sEMG) sensor engineered for robust, motion-resistant muscle measurement directly in true field environments.

  • Software Dashboard: A real-time signal processing engine providing normalised muscle performance metrics, automated fatigue detection, and predictive recovery tracking.

A Category Without Direct Competition

Capability GPS / Athlete Tracking Force / Dynamometry Research EMG BioSensr™
Field deployable Yes Partial No Yes
Muscle-specific measurement No No Yes Yes
Fatigue/injury classification No No Partial Yes
Time-to-recovery estimation No No No Yes
Scalable B2B SaaS Yes No No Yes
Research-grade accuracy No Yes Yes Yes

Case Study: Uncovering the Hidden Recovery Gap

Right Biceps Femoris (Hamstring) Tracking
Baseline Performance 100%
Acute Injury Phase 47%
Early Recovery (Conventional Clearance Zone) 86%
Conventional tools miss structural deficits here
True Neuromuscular Restoration 93%
BioSensr™ Objective Verification Layer

ON-FIELD DATA DEPLOYMENT

During real-world professional athletic monitoring, conventional strength metrics and subjective readiness scales often signal an early, superficial recovery.

Early recovery (~85%) can be rapid, but true neuromuscular restoration (~90%) is delayed and completely missed by conventional legacy monitoring systems.

Without the objective data layer provided by BioSensr, performance and medical staff are left blind to hidden deficits—unknowingly clearing elite players for full competitive exposure while still operating inside high-risk re-injury windows.

Validated by Elite Sports Organisations

Built on a foundation of clinical rigor and elite performance execution, our underlying data architecture is actively validated through a longitudinal research study in partnership with The University of Sydney, while undergoing real-world validation through on-field pilot program deployment with the Manly Warringah Sea Eagles.

Partner with the Future of Human Performance

IP Protected

Patent granted and active across 7 global jurisdictions (including USA, Canada, EU, UK, AU).

Scalable SaaS Architecture

Combining lightweight hardware with a high-margin, recurring software subscription revenue model.

Massive Addressable TAM

Targeting over 20,000 professional and semi-professional elite sports teams worldwide.